Canada markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.9198-0.2902 (-6.89%)
At close: 04:00PM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
6,518
3,172
2,321
3,085
Selling General and Administrative
5,373
3,264
1,615
1,440
Total Operating Expenses
11,891
6,437
3,935
4,525
Operating Income or Loss
-11,891
-6,437
-3,935
-4,525
Interest Expense
58.824
281.122
36.658
161.205
Total Other Income/Expenses Net
-7,103
-8,700
-
-
Income Before Tax
-19,042
-15,415
-3,961
-4,668
Income Tax Expense
-1,063
-1,001
-602.716
-902.801
Income from Continuing Operations
-17,978
-14,414
-3,358
-3,765
Net Income
-17,978
-14,414
-3,358
-3,765
Net Income available to common shareholders
-22,604
-19,040
-3,865
-3,765
Basic EPS
-
-2.54
-0.70
-0.70
Diluted EPS
-
-2.54
-0.70
-0.70
Basic Average Shares
-
7,500
5,526
5,332
Diluted Average Shares
-
7,500
5,526
5,332
EBITDA
-
-14,330
-3,120
-3,877